Vigilare Wealth Management Amicus Therapeutics, Inc. Transaction History

Vigilare Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 29, 2021	SELL	$9.2 - $23.86 $83,720 - $217,126	-9,100 Closed	0 $0
Q4 2020 Jan 14, 2021	SELL	$13.47 - $24.89 $63,309 - $116,983	-4,700 Reduced 34.06%	9,100 $210,000
Q3 2020 Oct 15, 2020	SELL	$12.89 - $15.89 $3,867 - $4,767	-300 Reduced 2.13%	13,800 $195,000
Q2 2020 Jul 20, 2020	SELL	$8.86 - $15.69 $35,440 - $62,760	-4,000 Reduced 22.1%	14,100 $213,000
Q1 2020 May 04, 2020	SELL	$6.63 - $11.16 $2,652 - $4,464	-400 Reduced 2.16%	18,100 $167,000
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $138,380 - $198,875	18,500 New	18,500 $165,000

312

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.